ITK JAK3 inhibitor

搜索文档
Aclaris Therapeutics (ACRS) Update / Briefing Transcript
2025-07-30 06:00
Aclaris Therapeutics (ACRS) Update / Briefing July 29, 2025 05:00 PM ET Speaker0Good day, and thank you for standing by. Welcome to the Aclaris Therapeutics ATI-two thousand one hundred thirty eight Phase 2a Topline Results and ITK Franchise Update Call. At this time, all participants are in a listen only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press 11 on your telephone.You will then hear an automated message ...